Centre for Developmental disabilities
Leuven, Flanders, 3000, Belgium
NCT Number: NCT02480452
The overall goal of this research proposal is the early prediction of the emergence of CVI and its characteristics on the basis of neuroimaging data.
The different steps that will be taken to achieve this goal will be:
1. To characterize CVI deficits in children; 2. To correlate the CVI characteristics with their motor profiles; 3. To characterize brain lesions in children with CVI; 4. To link the motor profile, CVI profile and brain metrics of the children.
Over the last 10 years, 488 children with and without CP have consulted at the CVI clinic in Leuven. All these children had a comprehensive visual perceptual assessment, cognitive evaluation and an ophthalmological assessment. Summarizing these data results in a quantitative visual perceptual profile for each individual patient. The goal is to prospectively extend this database to a number of 600 children. The project's primary objective is to relate the presence of CVI to the motor profiles of these children.
Of these 488 children, 300 have an MRI available. The goal is to analyze the retrospective MRI data of this clinical group and to prospectively extend this database by reassuring newly registered children will receive MRI with DTI. This will allow the investigation of the correlation between the brain metrics and the CVI characteristics in a large cohort.
Looking for future studies?
Notify Me3 year–6 year
All sexes
Observational
Leuven, Flanders, 3000, Belgium
Objective 1 &2: to investigate the relationship between the presence of CVI and the motor profiles of children diagnosed with CVI.
Part 1 Retrospective data A database, registering all children diagnosed with or at risk for CVI, is available through the Centre For Developmental Disabilities, Leuven. All these children have consulted at the CVI clinic. Their developmental age ranges between 3 and 6 years. All these children have had a thorough work-up, so that information is available regarding the diagnosis of CVI (L94 visual perceptual battery test score10 and CVI questionnaire11), the cognitive abilities of the child (performance and verbal IQ using WISC-II, SON-R or WPPSI-III-NL) together with the test results regarding motor functioning: visuospatial functioning (VMI12 and TVPS13), motor coherence tasks and gross motor function (movement ABC14).
All children standardly received a complete ophthalmological assessment. The consensus eye protocol, as introduced by the Flemish working group on CVI, was performed in each child, evaluating fixation of eyes, position and motility, acuity, refraction, contrast sensitivity, visual field, visual attention and viewing distance.
Part 2 Prospective data The database will continuously be updated and therefore, data from all new consulting children will be added consecutively.
Prospectively, a new test for the diagnosis of CVI will be applied. It concerns a newly developed tool for diagnosis of CVI, based on the L-POST and developed in collaboration with the research group of J. Wagemans. Normative data have been gathered for the age ranges 3 to 6 years. The diagnosis of CVI is made by comparing the results of the visual perceptual tests to the developmental age of the child, with a result <Pc 5 necessary for CVI to be confirmed.15 These tests are standardly performed during the consultations and do not require any additional time nor tests.
As in the retrospective cohort, cognitive and motor assessments will be performed.
The retrospective and prospective data together will allow us to relate the CVI characteristics to the motor profiles of the children.
Objective 3&4: To build a prediction model based on the correlations found between brain metrics and CVI characteristics.
Part 1 Retrospective data If clinically mandatory, children had an MRI of the brain performed either around the time of their CVI diagnosis or earlier in case they had a pre-existing condition. We will correlate quantified CVI measures to the location and extent of the underlying brain lesions, if present, and the (lack of) white matter tract integrity using structural MRI and DTI. Our neuromotor research team (FABER-UZ Leuven, CP reference centre) already developed a specific standardized imaging protocol for CP, mainly directed at detection of white matter damage. This protocol includes at least FLAIR, MPRAGE, and DTI sequences. First of all, the qualitative classification of the SCPE will be used to classify conventional MRI.16 In children with dyskinetic CP, the classification of K. Himmelmann can additionally be performed.17 To perform a more comprehensive qualitative and semi-quantitative evaluation of brain lesions visible on conventional MRI, the FIORI classification scale, recently developed in collaboration with our group, will be used.18 Additionally, quantitative evaluations of microstructural brain lesions will be realized through the reconstruction of white matter tracts (e.g. inferior longitudinal fasciculus) using DTI. In this way, we will be able to link a set of neural parameters to measures of visual perceptual deficits. The goal of this study is to identify MRI- and DTI-parameters that are able to discriminate between children with and without CVI on the one hand and between different CVI patterns on the other hand. We expect that combinations and interactions of different MRI- and DTI-parameters, instead of single parameters, will be better suited for prognosis of the presence of CVI and of its characteristics. If possible, supplementary volumetric data will be gathered using the same scan.
Over the last 10 years, we have already collected a large dataset of children with and without CP, seen at the CVI clinic in Leuven. Of these 400 children, 300 have an MRI available. The diagnosis of CVI was made when results on the visual perceptual tests were at a level <Pc 5 for the developmental age. The retrospective MRI data of this clinical group will be thoroughly analyzed in the various ways described above and subsequently correlated to the visual perceptual data. In this way, we will obtain a clearer insight in the relation between metrics of brain lesions and CVI characteristics.
Part 2 Prospective data Prospective data will be gathered in a similar way as the retrospective data collection. Children will preferably receive an MRI with DTI around the age of 5 years. Around this age, with the help of a child-friendly scanning protocol (developed by PhD student Marjolein Verly), anaesthesia can be avoided. In all children demonstrating clinical relevant CVI features, an MRI with DTI will be performed. Subsequently, data will be analyzed in a similar way as the retrospective MRI data.
The first part of the study is designed as a retrospective cohort study. Data is collected from the standardized tests that are routinely performed during the CVI consultations. Trained staff members of the Centre for Developmental Disabilities performed the tests.
Information regarding the age, the birth history and the school system the child is enrolled in.
The second part of the study is the prospective continuation of the retrospective cohort study. As during the retrospective part of the study, the same standardized tests are routinely performed during the CVI consultations and performed by the trained staff members of the Centre for Developmental Disabilities. However, prospectively, some additional tests will be performed
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline
Diagnostic assessment for CVI
Time frame: baseline
Outcome parameters for quantitative scoring of brain MRI
Time frame: baseline
Visual Motor Integration Test (VMI); Test of Visual Percepual Skills (TVPS)
Time frame: baseline
Movement ABC
Time frame: baseline
Standardized test evaluating motion coherence
Universitaire Ziekenhuizen KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.